Cheddar's weekly series "CannaBiz" focuses on the business of marijuana, and market opportunity in this space. Cheddar Anchor's Brad Smith and Baker Machado dive into the latest trends in this space.
This week Vermont became the ninth state to legalize recreational marijuana. It's also the first state to enact this through legislation. Marijuana Policy Project's Director of Communication Morgan Fox explains the state of regulation, and how his organization is pushing for greater legalization.
"If you look at polling in every state, and nationally there is majority support for making marijuana legal," said Fox. In October 2017, a Gallup poll found 64 percent of Americans support making marijuana legal.
Several marijuana companies are kicking off 2018 strong in the public market. Green Market Report's CEO and Editor-in-Chief Debra Borchardt explains the companies she see's capitalizing on the growing cannabis market.
Toronto-based Med Releaf is up nearly 20 percent in 2018. Borchardt says this company stands apart by being one of the lowest cost cannabis producers. "This is where we are seeing the real race in the marijuana community," says Borchardt.
Two other companies on Borchardt's watch list are Kush Bottles, and Aurora Cannabis.
At its annual health event on Tuesday, Google announced a series of changes to its search tool that it said will make it easier to access information about affordable health care services.
The Environmental Protection Agency (EPA) is proposing the nation's first-ever drinking water standard around polyfluoroalkyl substances (PFAS) or "forever chemicals."
It's Women's History Month and Tuesday marks Equal Pay Day. To honor the occasion, Laura Gassner Otting, author of Limitless: How to Ignore Everybody, Carve Your Own Path, and Live Your Best Life, spoke with Cheddar News' correspondent Shannon LaNier about how to properly value yourself and get the pay you deserve, regardless of your gender.
Southwest Airlines Co. on Tuesday outlined a plan to strengthen its operational resilience after a winter storm late last year led to widespread cancellations and delays.
Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up 75 percent for people living with diabetes starting in January 2024.
